NEW YORK (GenomeWeb) – Becton Dickinson today reported a 2 percent year over year increase in fiscal first quarter revenues as growth in both its Life Sciences and Medical segments was tempered by an unfavorable currency impact.

For the three months ended Dec. 31, BD reported revenues of $2.05 billion compared to $2.02 billion in the same quarter last year and beating analysts' consensus estimate of $2.01 billion. On a currency-neutral basis, revenues increased about 5 percent year over year, BD said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Germany's Project DEAL has come to an agreement with the publisher Wiley over journal access and open-access publishing, ScienceInsider reports.

A Canadian panel recommends public coverage of the gene therapy Kymriah if its cost comes down, the Globe and Mail reports.

Researchers uncover additional loci associated with lifespan, which the Telegraph says could be folded into a genetic test.

In Nucleic Acids Research this week: new accurate quantification by sequencing approach, CNV breakpoints in Plasmodium falciparum, and more.